The study, which has not been peer-reviewed, examined the link between certain preexisting conditions and COVID-19 mortality. Researchers searched several databases, including Medline and Ovid, for studies published between Dec. 1, 2019, and May 1. They included 19 studies in the meta-analysis. The 19 studies involved 61,455 patients with COVID-19.
Coronary heart disease, hypertension, congestive heart failure and cancer significantly increased the risk of mortality from COVID-19.
The risk of death from COVID-19 was:
● 2.4 times as high for those with coronary heart disease, compared to those without
● 2 times as high for those with hypertension, compared to those without
● 2.5 times as high for those with congestive heart failure, compared to those without
● 2 times as high for those with cancer, compared to those without
More articles on cardiology:
Estimated volume losses for 30 service lines
‘We are open, please come’: California hospital urges patients to seek emergency care
White House tables CDC reopening guidelines; hospitals question transparency of remdesivir distribution — 8 updates
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
